Status:
COMPLETED
Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Multiple Sclerosis
Respiration Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to describe respiratory disorders in patients with severe multiple sclerosis (EDSS from 6.5).
Eligibility Criteria
Inclusion
- Diagnosis criteria of multiple sclerosis (MS) fulfilling revised McDonald criteria (2010)
- EDSS score from 6.5
- no relapse during the 3 last months
- Informed consent prior to any study procedure
Exclusion
- Any severe Chronic Obstructive Pulmonary Disease (III or IV)
- Pregnancy or woman with childbearing potential
- contraindication to MRI
Key Trial Info
Start Date :
January 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03339817
Start Date
January 11 2018
End Date
November 6 2020
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Département de Neurologie-Groupe Hospitalier Pitié-Salpêtrière
Paris, Paris, France, 75013